Paper40246777
Therapeutic options for human papillomavirus-positive tonsil and base of tongue cancer.
Zupancic M and 3 others. J Intern Med, 2025. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Therapeutic options for human papillomavirus-positive tonsil and base of tongue cancer. Papers, record 40246777. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40246777
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Tongue Neoplasms | Major topic |
| Papillomavirus Infections | Major topic |
| Tonsillar Neoplasms | Major topic |
| Squamous Cell Carcinoma of Head and Neck | Major topic |
| Carcinoma, Squamous Cell | Major topic |
| Humans | |
| Papillomaviridae | |
| Immune Checkpoint Inhibitors | |
| Human Papillomavirus Viruses |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 232700PJ | Swedish Cancer Foundation | PubMed | ||
| Karolinska Institutet | PubMed | |||
| Not applicable | Stockholm City Council | PubMed |
Source PubMed
References196
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27699545 | Update on De-intensification and Intensification Studies in HPV. | Recent Results Cancer Res | 2017 | https://conductscience.org/library/papers/27699545 | PubMed |
| 2 | 35431082 | Longitudinal measurement of HPV copy number in cell-free DNA is associated with patient outcomes in HPV-positive oropharyngeal cancer. | Eur J Surg Oncol | 2022 | https://conductscience.org/library/papers/35431082 | PubMed |
| 3 | 25091798 | De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma: a systematic review and meta-analysis of current clinical trials. | Eur J Cancer | 2014 | https://conductscience.org/library/papers/25091798 | PubMed |
| 4 | 30584688 | Changes in incidence and prevalence of human papillomavirus in tonsillar and base of tongue cancer during 2000-2016 in the Stockholm region and Sweden. | Head Neck | 2019 | https://conductscience.org/library/papers/30584688 | PubMed |
| 5 | 32928035 | Communicative Participation and Quality of Life in Pretreatment Oral and Oropharyngeal Head and Neck Cancer. | Otolaryngol Head Neck Surg | 2021 | https://conductscience.org/library/papers/32928035 | PubMed |
| 6 | 29587383 | Protein Expression in Tonsillar and Base of Tongue Cancer and in Relation to Human Papillomavirus (HPV) and Clinical Outcome. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/29587383 | PubMed |
| 7 | 25993150 | Targeting the PI3K Pathway in Head and Neck Squamous Cell Carcinoma. | Am Soc Clin Oncol Educ Book | 2015 | https://conductscience.org/library/papers/25993150 | PubMed |
| 8 | 15386365 | Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients. | Int J Cancer | 2004 | https://conductscience.org/library/papers/15386365 | PubMed |
| 9 | 33425717 | The Tumor Microenvironment and Immunotherapy of Oropharyngeal Squamous Cell Carcinoma. | Front Oncol | 2020 | https://conductscience.org/library/papers/33425717 | PubMed |
| 10 | 31788102 | In vitro antitumor effects of FGFR and PI3K inhibitors on human papillomavirus positive and negative tonsillar and base of tongue cancer cell lines. | Oncol Lett | 2019 | https://conductscience.org/library/papers/31788102 | PubMed |
| 11 | 18172269 | Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine. | Clin Cancer Res | 2008 | https://conductscience.org/library/papers/18172269 | PubMed |
| 12 | 31838340 | Validation and characterisation of prognostically significant PD-L1+ immune cells in HPV+ oropharyngeal squamous cell carcinoma. | Oral Oncol | 2020 | https://conductscience.org/library/papers/31838340 | PubMed |
| 13 | 27718784 | Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck. | N Engl J Med | 2016 | https://conductscience.org/library/papers/27718784 | PubMed |
| 14 | 26095926 | The role of HPV RNA transcription, immune response-related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancer. | Int J Cancer | 2015 | https://conductscience.org/library/papers/26095926 | PubMed |
| 15 | 28029303 | E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group. | J Clin Oncol | 2017 | https://conductscience.org/library/papers/28029303 | PubMed |
| 16 | 19330833 | Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? | Int J Cancer | 2009 | https://conductscience.org/library/papers/19330833 | PubMed |
| 17 | 25631445 | Comprehensive genomic characterization of head and neck squamous cell carcinomas. | Nature | 2015 | https://conductscience.org/library/papers/25631445 | PubMed |
| 18 | 36228746 | Safety of Nivolumab Added to Chemoradiation Therapy Platforms for Intermediate and High-Risk Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: RTOG Foundation 3504. | Int J Radiat Oncol Biol Phys | 2023 | https://conductscience.org/library/papers/36228746 | PubMed |
| 19 | 28720154 | Human papillomavirus tumour status is not associated with a positive depression screen for patients with oropharyngeal cancer. | J Laryngol Otol | 2017 | https://conductscience.org/library/papers/28720154 | PubMed |
| 20 | 32771994 | CD163+ cytokine-producing cDC2 stimulate intratumoral type 1 T cell responses in HPV16-induced oropharyngeal cancer. | J Immunother Cancer | 2020 | https://conductscience.org/library/papers/32771994 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42626754 | Case Reports of Four Patients with HPV-Positive Head and Neck Cancer of Non-Oropharyngeal Origin Undergoing Liquid Biopsy for Circulating Cell-Free HPV-DNA before, during, and after Treatment. | Case Rep Oncol | 2026 | https://conductscience.org/library/papers/42626754 | PubMed |
| 42471999 | Dual targeting of PI3K and FGFR or CDK4/6 reveals synergistic responses in HPV-positive and HPV-negative oropharyngeal cancer spheroids. | Mol Ther Oncol | 2026 | https://conductscience.org/library/papers/42471999 | PubMed |
| 41972830 | What If Trojan Horse Nanoparticles Could Change the Game for HPV Gene-Targeted Therapies? | J Med Virol | 2026 | https://conductscience.org/library/papers/41972830 | PubMed |
| 41890267 | HPV-positive cancers at uncommon sites: a narrative review. | Oncol Rev | 2026 | https://conductscience.org/library/papers/41890267 | PubMed |
| 41419643 | Circulating cell free HPVDNA in HPV positive head and neck cancer reveals fast responders and early peakers during treatment. | Sci Rep | 2025 | https://conductscience.org/library/papers/41419643 | PubMed |
| 40246777 | Therapeutic options for human papillomavirus-positive tonsil and base of tongue cancer. | J Intern Med | 2025 | https://conductscience.org/library/papers/40246777 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40246777
GET https://conductscience.org/api/papers/v1/40246777/references?page=2